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Introduction 1
The association between reduced insulin/IGF-1 signalling and longevity has been 2 established in diverse model organisms using genetic, pharmacological and dietary 3
interventions (1), prompting interest in this as a paradigm to extend human lifespan. 4
However, the striking observations made in genetically modified invertebrates, which 5 share a common insulin and IGF-1 receptor, have been subtler in mammalian model 6 systems with isolated targeting of insulin or IGF-1 receptors (2). Whether these 7 discrepancies reflect a failure to simultaneously target the functionally overlapping 8 insulin and IGF-1 signalling apparatus remains unknown, and is an important barrier 9 to developing effective strategies to promote healthy ageing. Moreover, it is 10 increasingly appreciated that extension of lifespan may come at the expense of 11 extending time with poor health, resulting in a focus on interventions that prolong 12 healthy life, or healthspan (3). The literature describing whether reduced insulin and 13 IGF-1 signalling protects against ageing-associated functional decline is sparse, 14 particularly when applied to genetic interventions in mammalian models. Hence, we 15 set out to study whether reduced insulin and/or IGF-1 receptor expression extend 16 healthy life in mice. 17
18

Materials and methods 19
Acquisition, breeding and husbandry of mice: Mice were bred onto a C57BL/6J 20 background for >10 generations in a conventional animal facility with 12-hour light/dark 21 cycle. A standard chow diet (Beekay BK001E, B&K Universal Limited) was provided, 22
which contained 4.7% fat, 18.7% protein and 59.7% nitrogen free extract (16.3KJ/g). 23
As previously described (4), male insulin receptor halpoinsufficient mice (IRKO) were 24 crossed with female IGF-1 receptor halpoinsufficient mice (IGF-1RKO), resulting in 25 progeny with the following genotypes: 1) Wild-type (WT); 2) insulin receptor 1 halpoinsufficient (IRKO); 3) IGF-1 receptor halpoinsufficient; and 4) insulin and IGF-1 2 receptor halpoinsufficient (DKO). 15 male mice per genotype were observed during 3 assessment of healthspan. All procedures were performed according to accepted 4 standards of humane animal care, approved by the ethical review committee of the 5 University of Leeds, and conducted under license from the United Kingdom Home 6
Office. 7 8 Metabolic assessment: Whole capillary blood was sampled from tail vein, with glucose 9 concentrations determined in whole blood by a portable meter (Roche Diagnostics, 10 UK). Glucose and insulin tolerance tests were performed by blood sampling after an 11 intraperitoneal injection of glucose (1 mg/g; Sigma-Aldrich, UK) or human recombinant 12 insulin (0.75 units/kg, Actrapid; Novo Nordisk, Denmark), respectively (4). 13
14
Healthspan endpoints: Assessment of healthspan was made according to criteria 15 provided by a Home Office approved Veterinary Surgeon, based upon published 16 literature (5), to ensure animal welfare throughout the study. Animals were considered 17 to have reached their healthspan endpoint if one or more of the following conditions 18 was met: 1) Spontaneous death before one of the following endpoints; 2) Body 19 condition score ≤2 out of 5; 3) Body weight loss of ≥15% of the average highest body 20 weight, sustained for at least two consecutive weeks; 4) Hunched posture/starry 21 coat/abnormal gait of more than 48 hours duration; 5) Any progressively enlarging 22 subcutaneous lump/swelling; 6) Excessive hair loss, monitored over at least one week. 23
Assessment to confirm whether an animal had met a healthspan endpoint was made 24 by two independent observers except in the case of spontaneous death or body weight 25 loss of ≥15% of the average highest body weight, which were considered independent 1 of inter-observer variability. Animals were culled in accordance with Schedule 1 of The 2 Animals (Scientific Procedures) Act 1986 (Amended 2012) once a healthspan 3 endpoint was reached. In keeping with our United Kingdom Home Office Project 4 License (P144DD0D6) stipulations, any animals considered to be experiencing 5 excessive pain or distress (outside of the criteria mentioned above) were culled after 6 assessment by two independent observers blinded to genotype. 7 8 Nesting studies: Mice were caged individually and left overnight with a nestlet. The 9 next morning the cage was examined for the presence of a nest and images taken to 10 quantify nest building, according to an established validated protocol (6). Nest 11 photographs were taken by a blinded researcher, and subsequently scored by 4 12 genotype-blinded researchers per mouse, to derive a mean nesting score for each 13 mouse. Scoring criteria were as follows: 1) Nestlet not noticeably touched (more than 14 90% intact); 2) Nestlet partially torn (50-90% remaining intact); 3) Nestlet mostly 15
shredded but often no identifiable nest site: less than 50% of the Nestlet remains 16
intact, but less than 90% is within a quarter of the cage floor area; i.e., the cotton is 17 not gathered into a nest but is spread around the cage. The material may sometimes 18 be in a broadly defined nest area, but the critical definition here is that 50-90% has 19 been shredded; 4) An identifiable but flat nest: more than 90% of the Nestlet is torn 20 and the material is gathered into a nest within a quarter of the cage floor area, but the 21 nest is flat, with walls higher than mouse body height (of a mouse curled up on its side) 22
for less than 50% of its circumference; 5) A (near) perfect nest: more than 90% of the 23
Nestlet is torn and the nest is a crater, with walls higher than mouse body height for 24 more than 50% of its circumference. 25 6 1 Statistics: Data are presented as mean ± SEM. All genotypes were compared with 2 ANOVA or Kruskal-Wallis tests, as appropriate, with post hoc comparisons made 3 using t-tests or Mann-Whitney U tests. Statistical significance was defined as p<0.05. 4 5 Results 6
As previously described (4), we bred insulin receptor halpoinsufficient mice with IGF-7 1 receptor halpoinsufficient mice, producing progeny with the following genotypes: 8 wild-type (WT); insulin receptor halpoinsufficient (IRKO); IGF-1 receptor 9 halpoinsufficient (IGF-1RKO); insulin and IGF-1 receptor halpoinsufficient (DKO). 10
Male littermates (n=15/genotype) were then fed a standard chow diet and observed 11 by researchers blinded to genotype until spontaneous death or an a priori defined 12 humane endpoint described earlier. All genotypes gained weight during adulthood 13 (Figure 1a) , with mean weight at 18 months of age being significantly less in IRKO and 14 DKO than WT and IGF-1RKO littermates (Figure 1b) . At 20 months of age, this was 15 associated increased glucose tolerance (Figure 1c) , and increased insulin sensitivity 16 ( Figure 1d ) in all surviving IRKO and DKO versus WT and IGF-1RKO littermates. 17
Notably, body mass across genotypes correlated with glucose tolerance (R 2 = 0.48; 18 Nesting studies were then performed in all mice surviving to 24 months of age, as a 21 marker of behaviour and global cognitive performance. The mean nesting quality 22 score allocated by 4 blinded assessors using a validated methodology (6) was 23 significantly different between genotypes, with DKO exhibiting clearly superior 24 performance against other groups (Figure 2a ). Notably, nesting performance did not 7 correlate with body mass, and nesting scores in a subgroup of 3-month old mice from 1 this colony demonstrated that all genotypes produced high quality nests (Figure 2b) . 2 Importantly, the superior nesting scores of DKO were also associated with extended 3 survival free from markers of ill health that mandated euthanasia according to our 4 humane endpoint protocol (Log rank p=0.04 across all genotypes; Figure 2c ). When 5 comparing individual genotypes, only DKO survived significantly longer than WT (Log 6 rank p=0.004; median survival 868 versus 712 days), with survival of IRKO and IGF-7 Our study shows for the first time that genetically reduced insulin and IGF-1 signalling 11 extends healthspan and retards cognitive decline in male mice, suggesting that 12 observations made in invertebrates may be relevant to mammalian ageing. Notably, 13 studies linking reduced insulin or IGF-1 signalling to murine longevity and stress 14 resistance have found sexual dimorphism (7-12); hence it will be very important for 15 future studies to examine female DKO mice, rather than generalising the differences 16
we have observed in male mice. A striking observation from our data is that isolated 17 reduction in insulin or IGF-1 signalling is insufficient to significantly extend healthspan 18 parameters in male mice; this suggests a synergistic effect, possibly reflecting 19 functional compensation between these evolutionarily related receptors (13). 20
Moreover, our metabolic characterisation suggests that reduced body mass and 21 increased insulin sensitivity, two parameters often associated with longevity (14), are 22 not sufficient to denote healthy ageing, since the similar metabolic phenotype of IRKO 23 and DKO was not mirrored in their healthspan. In summary, our data may reconcile 24 conflicting observations from evolutionarily distant models of ageing, by emphasising 25 illustrating healthspan (Log rank p=0.04; n=15/genotype). AU -arbitrary units. 5
